Neuroactive steroids for treatment of CNS-related disorders

The present disclosure relates to methods of treating major depressive disorder (MDD) or postpartum depression (PPD) in a subject in need thereof with a combination of Compound (1) and an additional antidepressant, followed by continued administration of the additional antidepressant.

Saved in:
Bibliographic Details
Main Authors LASSER, ROBERT ALFONSO, DOHERTY, JAMES, GUNDUZ-BRUCE, HANDAN, BULLOCK, AMY E, JONAS, JEFFREY MARTIN, MARIANO, TIMOTHY Y, KANES, STEPHEN JAY
Format Patent
LanguageChinese
English
Published 01.11.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to methods of treating major depressive disorder (MDD) or postpartum depression (PPD) in a subject in need thereof with a combination of Compound (1) and an additional antidepressant, followed by continued administration of the additional antidepressant.
Bibliography:Application Number: TW202312105363